Previous studies demonstrated that WO plus GFX could robustly activate glycogen synthase kinase-3β (GSK-3β), a kinase that promotes tau hyperphosphorylation at multiple AD-associated sites 17, 18. The gene discussed is MAPT; the disease is Alzheimer disease.